FoxBio Company

FoxBio is a Company that will develop Antoxerene’s collection of small molecules that target senescent cells.
Industry:
Biopharma, Biotechnology, Life Science
Technology:
Geroscience
Investors Number:
2
Headquarters:
Lafayette, Louisiana, United States
Number Of Exists:
Venture - Series Unknown
Investor Type:
Company
Total Funding:
10000000
Founded Date:
2018
Last Funding Type:
Venture - Series Unknown
Last Funding Date:
2018